Oh Jiyoung, Choi Yon Sik, Kim Jun-Woo, Park Joong-Yeol, Kim Seung-Whan, Park Kun-Koo, Pak Youngmi Kim
Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul 138-736, Korea.
J Cell Biochem. 2005 Nov 1;96(4):786-94. doi: 10.1002/jcb.20551.
The proximal region -234 to (+58 bp) of low-density lipoprotein receptor (LDLR) is responsible for its up-regulation by sterol regulatory element binding protein (SREBP). However, the mechanism of sterol-independent repression of LDLR has not been determined yet. In this study, we observed that there was an early induction and a later repression of LDLR by phorbol ester (PMA) in SK-Hep1 hepatocarcinoma cells and investigated the mechanisms through which PMA repressed LDLR transcription. SK-Hep1 cells were exposed to PMA and LDLR mRNA was evaluated by RT-PCR and Northern blot analysis. The effect of phorbol ester on LDLR transcriptional activity was studied using transient transfection of LDLR promoter-luciferase constructs. Overexpression of N-SREBP-2, a dominant positive SREBP2, did not reverse the PMA-repressed LDLR promoter activity. Serial deletion of LDLR promoter revealed that the region between -1,563 and -1,326 was responsible for the repression. The pretreatment with SB202190, an inhibitor for p38 mitogen-activated protein kinase pathway (p38-MAPK), but not other signaling inhibitors, reversed the PMA-induced repression. The 24 h-treatment with PMA efficiently arrested the SK-Hep1 cell cycle at G0/G1 as demonstrated by FACS analysis and decreased the 3H-thymidine incorporation. The PMA-induced repression of LDLR transcription may be exerted by the factor(s), not SREBP2, induced or modified by p38-MAPK-mediated signaling pathway and associated with cell cycle blockage.
低密度脂蛋白受体(LDLR)近端区域-234至(+58碱基对)负责其由固醇调节元件结合蛋白(SREBP)上调。然而,LDLR固醇非依赖性抑制的机制尚未确定。在本研究中,我们观察到佛波酯(PMA)在SK-Hep1肝癌细胞中对LDLR有早期诱导和后期抑制作用,并研究了PMA抑制LDLR转录的机制。将SK-Hep1细胞暴露于PMA,通过逆转录聚合酶链反应(RT-PCR)和Northern印迹分析评估LDLR mRNA。使用LDLR启动子-荧光素酶构建体的瞬时转染研究佛波酯对LDLR转录活性的影响。显性阳性SREBP2的N-SREBP-2过表达并未逆转PMA抑制的LDLR启动子活性。LDLR启动子的系列缺失显示-1563至-1326之间的区域负责这种抑制作用。用p38丝裂原活化蛋白激酶途径(p38-MAPK)抑制剂SB202190预处理可逆转PMA诱导的抑制作用,而其他信号抑制剂则不能。如荧光激活细胞分选(FACS)分析所示,PMA处理24小时可有效使SK-Hep1细胞周期停滞在G0/G1期,并减少3H-胸腺嘧啶掺入。PMA诱导的LDLR转录抑制可能由p38-MAPK介导的信号通路诱导或修饰的因子(而非SREBP2)发挥作用,并与细胞周期阻滞相关。